This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Bernstein Reaffirms Their Buy Rating on Cigna (CI)

Tipranks - Tipranks - Wed Jun 10, 6:04AM CDT

Bernstein analyst Lance Wilkes maintained a Buy rating on Cigna today and set a price target of $371.00.

Introducing TipRanks MCP for Agents

According to TipRanks, Wilkes is a 4-star analyst with an average return of 11.5% and a 64.17% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as HCA Healthcare, CVS Health, and UnitedHealth.

In addition to Bernstein, Cigna also received a Buy from Mizuho Securities’s Ann Hynes in a report issued yesterday. However, on June 4, Wells Fargo maintained a Hold rating on Cigna (NYSE: CI).

See the top stocks recommended by analysts >>

Based on Cigna’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $68.49 billion and a net profit of $1.65 billion. In comparison, last year the company earned a revenue of $65.5 billion and had a net profit of $1.32 billion

Read More on CI:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).